跳至主要内容
临床试验/CTRI/2012/05/002657
CTRI/2012/05/002657已完成4 期

e-BioMatrix Post Marketing Surveillance PMR Registry - e-BMX PMR

Biosensors Europe SA Moges Switzerland0 个研究点目标入组 4,000 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
4,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • 1. Patients that need a treatment with a BioMatrix drug-eluting stent;
  • 2. Presence of one or more coronary artery stenoses in a native coronary artery or a saphenous bypass graft from 2.25 to 4.0 mm in diameter that can be covered with one or multiple stents;
  • 3. No limitation on the number of treated lesions, and vessels, and lesion length.

排除标准

  • 1. Inability to provide informed consent;
  • 2. Patients needing additional stent NOT of the BioMatrix type;
  • 3. Patients receiving next to the BioMatrix stent also other coronary, vascular
  • interventions, for example dilation.

研究者

发起方
Biosensors Europe SA Moges Switzerland

相似试验